ATE87467T1 - Pharmazeutische zubereitung. - Google Patents

Pharmazeutische zubereitung.

Info

Publication number
ATE87467T1
ATE87467T1 AT89850006T AT89850006T ATE87467T1 AT E87467 T1 ATE87467 T1 AT E87467T1 AT 89850006 T AT89850006 T AT 89850006T AT 89850006 T AT89850006 T AT 89850006T AT E87467 T1 ATE87467 T1 AT E87467T1
Authority
AT
Austria
Prior art keywords
preparations
particles
pharmaceutical
pharmaceutical preparation
carrier
Prior art date
Application number
AT89850006T
Other languages
English (en)
Inventor
Christer Nystroem
Marie Westerberg
Per Nilsson
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Application granted granted Critical
Publication of ATE87467T1 publication Critical patent/ATE87467T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
AT89850006T 1988-01-13 1989-01-12 Pharmazeutische zubereitung. ATE87467T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8800080A SE8800080L (sv) 1988-01-13 1988-01-13 Laekemedelskomposition
EP89850006A EP0324725B1 (de) 1988-01-13 1989-01-12 Pharmazeutische Zubereitung

Publications (1)

Publication Number Publication Date
ATE87467T1 true ATE87467T1 (de) 1993-04-15

Family

ID=20371045

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89850006T ATE87467T1 (de) 1988-01-13 1989-01-12 Pharmazeutische zubereitung.

Country Status (6)

Country Link
EP (2) EP0396599A1 (de)
AT (1) ATE87467T1 (de)
AU (1) AU2923389A (de)
DE (1) DE68905613T2 (de)
SE (1) SE8800080L (de)
WO (1) WO1989006533A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2685635B1 (fr) * 1991-12-27 1995-06-30 Lvmh Rech Particules solides complexes comprenant une substance solide biologiquement active, leur mode de preparation et compositions a usage topique les renfermant destinees au traitement de surfaces biologiques.
US5876758A (en) * 1989-08-04 1999-03-02 Lvmh Recherche Solid complex particles comprising a biologically active solid substance, mode of preparation and compositions for topical use containing them and intended to treat biological surfaces
US5385142A (en) * 1992-04-17 1995-01-31 Infrasonics, Inc. Apnea-responsive ventilator system and method
SE9803239D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab Composition for the treatment of acute pain
SE9803240D0 (sv) 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
DK1587514T3 (da) * 2003-01-31 2006-10-16 Orexo Ab Hurtigvirkende farmaceutisk præparat
GB0423800D0 (en) 2004-10-27 2004-12-01 Orexo Ab New pharmaceutical formulations
NZ556717A (en) * 2005-02-10 2010-09-30 Orexo Ab Pharmaceutical compositons useful in the transmucosal administration of drugs using microparticles attached to the surface of larger carrier particles
WO2006103417A1 (en) * 2005-03-28 2006-10-05 Orexo Ab New pharmaceutical compositions useful in the treatment of parkinson's disease
JP2008534562A (ja) * 2005-03-28 2008-08-28 オレクソ・アクチエボラゲット 偏頭痛の治療に有用な新しい製薬組成物
US20100233257A1 (en) * 2006-06-09 2010-09-16 Ethypharm Low dose sublingual tablets of opioid analgesics and preparation process
TW200824693A (en) 2006-08-28 2008-06-16 Jazz Pharmaceuticals Inc Pharmaceutical compositions of clonazepam and methods of use thereof
US8475832B2 (en) 2009-08-07 2013-07-02 Rb Pharmaceuticals Limited Sublingual and buccal film compositions
US8940330B2 (en) 2011-09-19 2015-01-27 Orexo Ab Abuse-resistant pharmaceutical composition for the treatment of opioid dependence

Also Published As

Publication number Publication date
EP0324725A1 (de) 1989-07-19
DE68905613D1 (de) 1993-05-06
AU2923389A (en) 1989-08-11
EP0324725B1 (de) 1993-03-31
SE8800080D0 (sv) 1988-01-13
EP0396599A1 (de) 1990-11-14
DE68905613T2 (de) 1993-10-07
WO1989006533A1 (en) 1989-07-27
SE8800080L (sv) 1989-07-14

Similar Documents

Publication Publication Date Title
HUT55220A (en) Process for producing pharmaceutical composition suitable for systemic administration through the skin and comprising deprenyl as active ingredient
EE9900075A (et) 7a-( -aminoalküül)östratrieenid, nende valmistamise meetod, 7a-( -aminoalküül)östratrieene sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks
PT81839B (pt) Processo de preparacao de formulacoes com propulsores de aerosol a base de clorofluorocarbono contendo medicamento
SE8504720L (sv) Ny lekemedelsberedning
FI894637A (fi) Menetelmä mikroemulsion käsittävän farmaseuttisen formulaation valmistamiseksi
IT8820145A0 (it) Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.
HU903876D0 (en) Pesticide preparatives containing n-phenyl-pyrazole derivatives and process for producing the active substance
DE68905613D1 (de) Pharmazeutische zubereitung.
NO904754L (no) Kapsel for innkapsling av biologisk aktive materialer, fremgangsmaate for fremstilling av denne, samt anvendelse derav.
DE3875108D1 (de) Physiologisch aktives polypeptid und pharmazeutische komposition.
IT1229562B (it) Composizioni farmaceutiche antivirali ed immunostimolanti e procedimento per la loro preparazione.
SE8701479L (sv) Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav
AR243180A1 (es) Procedimiento para la obtencion de 3,4-dihidro-2h-benzopiranos sustituidos.
DE68902300T2 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
DK13089A (da) Substituerede 5,6,7,8-tetrahydro-4h-thieno-(2,3-d)azepin-forbindelser, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
FI894546A (fi) Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi
DE59001005D1 (de) Hilfsmittelfreie riboflavingranulate.
IL81232A0 (en) Pharmaceutical composition with sustained release of the active component and a process for the preparation thereof
HUT44764A (en) Process for producing new sulfonamidoethyl derivatives and pharmaceutical preparations comprising them as active substance
FI960587A (fi) Substituoituja bentseenisulfonyyliureoita, ja -tioureoita, menetelmä niiden valmistamiseksi ja niiden käyttö farmaseuttisen valmisteen valmistukseen sekä niitä sisältävät farmaseuttiset valmisteet
HUT43781A (en) Process for preparing pharmaceutical and the active substance
HU904062D0 (en) Process for producing substituted 3-amino-sydnonimines and pharmaceutical preparations containing these compounds as active substance
DE68926469D1 (de) Alkaloid-Verbindungen, pharmazeutische Zubereitungen und Verwendungsmethode
HU895656D0 (en) Insecticides and nematocides comprising benzisothiazole derivatives and process for producing the active ingredients
ZA87500B (en) Symmetrical o-substituted dioximes of benzo-fused beta-diketocycloalkylenes,the processes for their preparation and their application as drugs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties